Seeking Alpha

CVS Caremark (CVS -0.2%) looks like a good defensive long-term play, according to Stephanie...

CVS Caremark (CVS -0.2%) looks like a good defensive long-term play, according to Stephanie Link. She likes management's focus on quality of contracts over pricing and sees a continual grab of market share from Walgreen. If the WAG-ESRX continues to the end of the year, factor in another $0.02-$0.03 to the bottom line of CVS.
Comments (2)
  • "Quality of contracts" should be the focus of some other drug store chains as well!
    11 Jul 2012, 01:32 PM Reply Like
  • They will raise guidance when they report 2nd qtr earnings for qtr 3 and year...at least 3 cents each. Also will talk about additional buy backs in early Dec. and I predict they will at that time also raise 2013 dividend to .20 (.80 year)
    11 Jul 2012, 02:49 PM Reply Like
DJIA (DIA) S&P 500 (SPY)